TY - JOUR
T1 - Cell surface activation of the alternative complement pathway by the fusion protein of measles virus
AU - Devaux, Patricia
AU - Christiansen, Dale
AU - Plumet, Sébastien
AU - Gerlier, Denis
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2004/6
Y1 - 2004/6
N2 - Measles virus (MV)-infected cells are activators of the alternative human complement pathway, resulting in high deposition of C3b on the cell surface. Activation was observed independent of whether CD46 was used as a cellular receptor and did not correlate with CD46 down-regulation. The virus itself was an activator of the alternative pathway and was covered by C3b/C3bi, resulting in some loss in infectivity without loss of virus binding to target cells. The cell surface expression of MV fusion (F), but not haemagglutinin, envelope protein resulted in complement activation of the Factor B-dependent alternative pathway in a dose-dependent manner and F-C3b complexes were formed. The underlying activation mechanism was not related to any decrease in cell surface expression of the complement regulators CD46 and CD55. The C3b/C3bi coating of MV-infected cells and virus should ensure enhanced targeting of MV antigens to the immune system, through binding to complement receptors.
AB - Measles virus (MV)-infected cells are activators of the alternative human complement pathway, resulting in high deposition of C3b on the cell surface. Activation was observed independent of whether CD46 was used as a cellular receptor and did not correlate with CD46 down-regulation. The virus itself was an activator of the alternative pathway and was covered by C3b/C3bi, resulting in some loss in infectivity without loss of virus binding to target cells. The cell surface expression of MV fusion (F), but not haemagglutinin, envelope protein resulted in complement activation of the Factor B-dependent alternative pathway in a dose-dependent manner and F-C3b complexes were formed. The underlying activation mechanism was not related to any decrease in cell surface expression of the complement regulators CD46 and CD55. The C3b/C3bi coating of MV-infected cells and virus should ensure enhanced targeting of MV antigens to the immune system, through binding to complement receptors.
UR - http://www.scopus.com/inward/record.url?scp=2942644452&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2942644452&partnerID=8YFLogxK
U2 - 10.1099/vir.0.79880-0
DO - 10.1099/vir.0.79880-0
M3 - Article
C2 - 15166451
AN - SCOPUS:2942644452
SN - 0022-1317
VL - 85
SP - 1665
EP - 1673
JO - Journal of General Virology
JF - Journal of General Virology
IS - 6
ER -